| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |